Mexico Electrocardiograph (ECG) Market Size and Share
| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 14.66 Million |
| Market Size (2030) | USD 18.86 Million |
| CAGR (2025 - 2030) | 5.17% |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Mexico Electrocardiograph (ECG) Market Analysis by Mordor Intelligence
The Mexico Electrocardiograph Market size is estimated at USD 14.66 million in 2025, and is expected to reach USD 18.86 million by 2030, at a CAGR of 5.17% during the forecast period (2025-2030).
The growth of the electrocardiograph (ECG) market in Mexico is influenced by various factors, including the rising prevalence of cardiovascular diseases, technological advancements in ECG, increased healthcare expenditure, and a growing emphasis on preventive healthcare. In addition, initiatives aimed at reducing CVD risk factors, such as campaigns for healthy lifestyles and regular screenings, lead to higher demand for ECG diagnostics.
The rising prevalence of high blood pressure in Mexico is a significant factor driving the growth of the country's ECG market. According to the 2023 National Health and Nutrition Survey (Ensanut), 29.9% of adults in Mexico suffer from high blood pressure. Additionally, data published by Mexico's Ministry of Health in May 2024 indicates that 40 million people in the country are affected by this condition. If left untreated or improperly managed, high blood pressure can result in severe health complications, such as myocardial infarctions and cerebrovascular events, which are among the leading causes of morbidity in Mexico. These alarming statistics underscore the increasing demand for diagnostic tools like ECG devices, as highlighted by the head of the Hemodynamics Service at Juárez de México Hospital (HJM) in 2024. Thus, the growing need for effective cardiovascular monitoring solutions such as ECG is expected to contribute significantly to the expansion of the ECG market in Mexico over the forecast period.
Furthermore, the growth of the ECG market in Mexico is being driven by various factors, including public health initiatives, such as those by the Mexican Social Security Institute (IMSS), which play a significant role in driving this growth. For instance, in August 2024, the Mexican Social Security Institute (IMSS) emphasized the importance of recognizing syncope symptoms. This knowledge can help individuals seek timely medical attention or assist someone experiencing the episode. IMSS also recommends complementary studies, including electrocardiograms to detect heart rhythm alterations and echocardiograms to identify any abnormalities in the heart's valves or walls. Such efforts by IMSS enhance public health awareness and increase the demand for diagnostic tools like ECGs, thereby supporting the growth of the ECG market in Mexico.
Therefore, the high burden of cardiovascular diseases coupled with public health initiatives are likely to increase the demand for early diagnosis using ECG devices, boosting the market growth over the forecast period. However, the high initial investment for advanced ECG devices is expected to hinder the market growth over the forecast period.
Mexico Electrocardiograph (ECG) Market Trends and Insights
Holter ECG Systems Segment is Expected to Have Significant Growth in the Market Over the Forecast Period
Holter ECG Systems are portable devices that continuously monitor the electrical activity of the heart for an extended period, usually 24 to 48 hours, though they can monitor for longer durations. The Holter ECG systems segment is experiencing notable growth in Mexico, driven by several factors, such as the increasing incidence of cardiac diseases coupled with the growing elderly population and supporting healthcare infrastructure.
Improved healthcare infrastructure and enhanced access to medical facilities are enabling more patients to benefit from continuous cardiac monitoring, leading to higher utilization rates of Holter ECG devices. For instance, in February 2024, the “Gral. Ignacio Zaragoza” Regional Hospital in Mexico initiated significant renovations, focusing on critical patient care areas. This effort aligned with the broader strategy to enhance healthcare services and infrastructure. As part of this initiative, the hospital received 798 pieces of equipment and furniture in 2023 to strengthen the operational capacity of the Institute of Social Security and Services for State Workers (ISSSTE)'s medical units across the country.
Notably, as per the same source, healthcare personnel were equipped with an electrocardiography monitor (Holter) and other essential devices. These advancements in healthcare infrastructure and the increased availability of Holter ECG devices are expected to contribute significantly to the growth of the Holter ECG segment in Mexico, reflecting the country's commitment to improving patient outcomes. Therefore, with the nation enhancing its healthcare infrastructure and expanding access to medical services, the Holter ECG segment stands ready for growth, particularly given the country's substantial burden of cardiovascular diseases.
Resting ECG Systems Segment is Expected to Have Fastest Growth in the Market Over the Forecast Period
Resting ECG Systems are diagnostic tools used to record the heart's electrical activity while the patient is at rest. This standard form of electrocardiography is usually performed in a clinical setting and provides valuable information about heart rhythm, rate, and overall functioning. The Resting ECG systems segment is anticipated to exhibit the fastest growth in the Mexican ECG market due to several contributing factors, such as recent advancements in ECG technology, growing emphasis on primary healthcare in Mexico, and growing public awareness of heart health.
The integration of ECG devices with other cardiovascular monitoring tools is pivotal in driving the growth of the ECG market in Mexico. These advancements are making ECG monitoring more accessible to both patients and healthcare providers, thereby addressing the rising demand for efficient diagnostic solutions. For instance, in October 2024, OMRON achieved significant progress in preventing cardiovascular diseases through innovations like the Complete device. This advanced blood pressure monitor not only measures blood pressure but also records the electrocardiogram (ECG) in real-time, enabling early detection of heart conditions such as atrial fibrillation (AFib), a significant risk factor for strokes. Therefore, in Mexico, the resting ECG segment is poised for substantial growth, driven by technological advancements. These innovations enable simultaneous blood pressure monitoring and ECG readings in resting conditions, directly addressing the rising prevalence of cardiovascular diseases and underscoring the urgent need for early diagnosis.
Furthermore, the growing prevalence of hypertension in Mexico is a significant factor influencing the expansion of the country's resting ECG segment, as hypertension is a considerable risk factor for altering the cardiac impulses in the heart. For instance, as of week 47 in 2024, the National Epidemiological Surveillance System's Epidemiological Bulletin reported 526,649 cases of hypertension. The Central region of Mexico records the highest prevalence, particularly in the State of Mexico and Mexico City, with females being predominantly affected. This rising burden of hypertension underscores the increasing demand for diagnostic tools like ECG devices, driving segment growth in the country.
Therefore, the resting ECG systems segment is expected to experience the fastest growth within the Mexican ECG market driven by the increasing prevalence of cardiovascular diseases, and enhanced technology in resting ECG devices.
Competitive Landscape
The ECG market in Mexico is competitive and rapidly evolving, driven by technological advancements and increasing healthcare demands. While established multinational companies have a significant presence, opportunities exist for local manufacturers and innovative new players. Some of the major players in the market include Contec Medical Systems Co., Ltd, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Koninklijke Philips N.V., SCHILLER, and GE Healthcare, among others.
Mexico Electrocardiograph (ECG) Industry Leaders
-
Koninklijke Philips N.V.
-
GE Healthcare
-
SCHILLER
-
Contec Medical Systems Co., Ltd
-
Shenzhen Mindray Bio-Medical Electronics Co., Ltd
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- November 2024: Mexico's Ministry of Health outlined five primary objectives in the Health Sector Work Program for 2024 - 2030. One key commitment is to ensure that every clinic and hospital is stocked with essential medicines, supplies, and equipment. This notably includes cardiovascular monitoring devices, such as ECGs.
- July 2024: A specialist in image-guided therapy at Philips Mexico emphasized the company's commitment to enhancing patient care. By seamlessly integrating advanced technologies like diagnostic ECG, continuous mobile outpatient telemetry, echocardiography, and sophisticated cardiac imaging, Philips empowers physicians to gain a comprehensive understanding of their patients. This timely and accessible data not only elevates the experience for both patients and staff but also allows doctors to provide tailored, personalized care.
Mexico Electrocardiograph (ECG) Market Report Scope
As per the scope of the report, an electrocardiograph (ECG) device is a medical instrument used to measure and record the electrical activity of the heart. The Mexico ECG market report provides a comprehensive analysis of the current state and growth potential of the ECG market in the country. The Mexico electrocardiograph (ECG) market is segmented by product type, which includes resting ECG systems, stress ECG systems, Holter ECG systems, and ECG management software. The report offers the market size in terms of both value (in USD) and volume (in units) for the above segments.
| Resting ECG Systems |
| Stress ECG Systems |
| Holter ECG Systems |
| ECG Management Software |
| By Product Type | Resting ECG Systems |
| Stress ECG Systems | |
| Holter ECG Systems | |
| ECG Management Software |
Key Questions Answered in the Report
How big is the Mexico Electrocardiograph Market?
The Mexico Electrocardiograph Market size is expected to reach USD 14.66 million in 2025 and grow at a CAGR of 5.17% to reach USD 18.86 million by 2030.
What is the current Mexico Electrocardiograph Market size?
In 2025, the Mexico Electrocardiograph Market size is expected to reach USD 14.66 million.
Who are the key players in Mexico Electrocardiograph Market?
Koninklijke Philips N.V., GE Healthcare, SCHILLER, Contec Medical Systems Co., Ltd and Shenzhen Mindray Bio-Medical Electronics Co., Ltd are the major companies operating in the Mexico Electrocardiograph Market.
What years does this Mexico Electrocardiograph Market cover, and what was the market size in 2024?
In 2024, the Mexico Electrocardiograph Market size was estimated at USD 13.90 million. The report covers the Mexico Electrocardiograph Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Mexico Electrocardiograph Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
Mexico Electrocardiograph (ECG) Market Report
Statistics for the 2025 Mexico Electrocardiograph (ECG) market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Mexico Electrocardiograph (ECG) analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
